SecBot SecBot
Insider Cluster (6 insiders) ·Filed May 26, 2026

PHVS

Pharvaris N.V.
BEARISH
Impact 5/10
Horizonweeks Processed5mo ago
Insider cluster: 6 insiders, $1.4M total
Actionable Insight ▼ Bearish

The cluster is small relative to market cap but broad-based across C-suite and board. With no 10b5-1 pattern and no offsetting buys, this is a modestly bearish signal. Monitor for upcoming earnings, pipeline updates (PHVS is a clinical-stage biotech), or a material agreement that may have prompted the selling. If a catalyst like data readout or financing is imminent, the selling could be informed, but at current scale, it does not warrant immediate action.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$29.47
T+0 close · May 26, 2026 · via day close
Latest settled
+23.48%
T+60 · $36.39
Vs SPY
+21.60%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 27 $29.47entry
  2. T+1 · 6mo ago +1.32%α +0.77% · $29.86
  3. T+5 · 6mo ago +2.27%α +1.80% · $30.14
  4. T+20 · 5mo ago +13.00%α +14.90% · $33.30
  5. T+60 · 3mo ago +23.48%α +21.60% · $36.39

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Six Pharvaris insiders, including the CEO, CFO, and CCO, sold a total of $1.38M in stock over a 7-day window. The cluster is 100% open-market sales with no offsetting purchases, and the CEO's sale is notable for its timing. At $2.1B market cap, the total represents ~0.07%, below the 0.1% materiality threshold, but the breadth of C-suite participation and the absence of any 10b5-1 pattern elevate the signal. The cross-filing actuarial verdicts show this cluster-insider-trades pattern is an AMPLIFIER when combined with other contexts, but no other material cross-filings (earnings, offering, restatement) are present in the provided context to trigger an override.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
6

Key Facts

  • Six insiders sold a total of $1.38M in open-market sales over 7 days (May 14–21, 2026).
  • CEO Berndt Modig sold 2,300 shares at $29.22 for $67K, his first sale in the cluster window.
  • CFO/CLO David Nassif sold 10,000 shares at $30.31 for $303K on May 21, the largest single trade.
  • Director Elisabeth Bjork sold 10,000 shares at $29.32 for $293K on May 20, following derivative exercises.
  • CCO Wim Souverijns sold 10,000 shares at $29.92 for $299K on May 15.
  • Total cluster value of $1.38M is ~0.07% of Pharvaris's $2.1B market cap, below the 0.1% materiality threshold.
  • No 10b5-1 plan disclosures or regular pattern in sale sizes/dates to suggest routine liquidity-driven sales.
  • All six insiders sold; zero insider purchases in the cluster window.

Financial Impact

Total insider sales of $1.38M represent ~0.07% of Pharvaris's $2.1B market cap, below the 0.1% materiality threshold for a standalone cluster, but the breadth of C-suite participation (CEO, CFO, CCO) and lack of purchases is notable.

insider ownershipmarket sentiment

Risk Factors

  • Insider selling may signal lack of confidence ahead of a catalyst (e.g., clinical trial readout, regulatory update).
  • No offsetting purchases, all six insiders sold, creating a uniform bearish signal.
  • CEO sale, though small, is the first in the cluster window and could be informational.
  • Clinical-stage biotech risk: any negative pipeline news could amplify the selling signal ex post.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1779831760828

Track record

51 reports on PHVS

Performance horizon

15 of 17 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 18 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
  3. Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  4. Nov 12, 20264d ago 6-K Neutral 4/10 No price data
  5. Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
  6. Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
  7. Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  8. Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
  9. Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
  10. Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
Showing 10 of 51

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026